Lung Cancer Screening Manager [iPhone]

RADIOLOGiQ, LLCが配信するiPhoneアプリ「Lung Cancer Screening Manager」の評価や口コミやランキング推移情報です。このアプリには「メディカル」「教育」などのジャンルで分類しています。APPLIONでは「Lung Cancer Screening Manager」の他にもあなたにおすすめのアプリのレビューやみんなの評価や世界ランキングなどから探すことができます。

Lung Cancer Screening Manager

RADIOLOGiQ, LLC 無料 iPhone / iPad対応メディカル教育 64bit

Trend

AppStoreでチェック！

iPhone
iPad

RADIOLOGiQ, LLCのメディカル系アプリ

「Lung Cancer Screening Manager」は、RADIOLOGiQ, LLCが配信するメディカル系アプリです。

メディカル教育

このアプリの話題とニュース

新バージョン7.4.1が配信開始。新機能や改善アップデートがされています。
2014年8月7日(木)にiPhoneとiPad両対応のユニバーサルアプリとしてリリース！

最新更新情報

version7.4.1が、2019年6月10日(月)にリリース

---Version 7.4.1 Update---
• Redesigned graphic within Fleischner module for multiple ≥6 mm ground-glass nodules

---Version 7.4 Update ---
*** Support for ACR Lung-RADS version 1.1, introduced May 2019 ***
Management updates include:
• new recommendations for 20.0-29.9 mm ground-glass lung nodules on lung screening
• new recommendations for Lung-RADS 4B and 4X situations in setting of baseline screening and new nodules on follow-up screening
• support for nodule sizing in tenths of a millimeter during lung screening (Lung-RADS 1.1), instead of whole millimeters (Lung-RADS 1.0)

Other updates in this version:
• Updated Fleischner and Lung-RADS nodule workflow recommendations
• Improved date projection feature for follow-up CT scheduling
• Improved handling of solid and part-solid lung nodule growth situations in Lung-RADS
• More elegant user interface for Fleischner guideline module
• Substantially improved auto-scrolling after selection of different lung nodule characteristics

使い方や遊び方

Indeterminate lung nodules are frequently discovered on CT imaging - either during low-dose lung cancer screening or incidentally on CT studies obtained for other reasons.

The most up-to-date guidelines for managing lung nodules discovered during lung screening and incidentally discovered lung nodules are elegantly integrated in this app, in addition to a convenient tool for estimating the malignancy risk for any lung nodule.

This app was developed as a public service by two academic cardiothoracic radiologists and recognized medical educators, and is provided free of charge and free of advertising to the medical community.